SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
16-Jul-24 4:30 PM View: | Transgenomic Inc. (PRPO) | 15-Jul-24 | Grant | 2,157 | $4.63 | $9,986.91 | 29% 7.46K to 9.62K | |
17-Apr-24 4:21 PM View: | Transgenomic Inc. (PRPO) | 15-Apr-24 | Grant | 3,153 | $6.66 | $20,999.00 | 73% 4.31K to 7.46K | |
26-Oct-23 4:30 PM View: | Transgenomic Inc. (PRPO) | 24-Oct-23 | Grant | 4,005 | -- | -- | 1322% 0.3K to 4.31K | |
14-Sep-23 4:39 PM View: | Transgenomic Inc. (PRPO) | 12-Sep-23 | Grant | 6,060 | -- | -- | 100% 0 to 6.06K | |
09-Dec-22 8:23 PM View: | Oncocyte Corp (OCX) | 01-Dec-22 | Option Exercise | 250,000 | -- | -- | 75% 333.21K to 583.21K | |
18-Aug-22 4:05 PM View: | Oncocyte Corp (OCX) | 16-Aug-22 | Private Purchase | 40,000 | $0.96 | $38,400.00 | 14% 293.21K to 333.21K | |
17-Mar-22 9:26 PM View: | Oncocyte Corp (OCX) | 16-Mar-22 | Private Purchase | 50,000 | $1.28 | $64,150.00 | 21% 243.21K to 293.21K | |
02-Jul-21 9:32 PM View: | Oncocyte Corp (OCX) | 01-Jul-21 | Payment of Exercise | 15,834 | -- | -- | (6%) 259.05K to 243.21K | |
02-Jul-21 9:32 PM View: | Oncocyte Corp (OCX) | 01-Jul-21 | Option Exercise | 65,000 | -- | -- | 33% 194.05K to 259.05K | |
02-Jul-21 1:59 PM View: | Oncocyte Corp (OCX) | 30-Jun-21 | Payment of Exercise | 25,873 | -- | -- | (12%) 219.92K to 194.05K | |
02-Jul-21 1:59 PM View: | Oncocyte Corp (OCX) | 07-May-21 | Option Exercise | 106,221 | -- | -- | 93% 113.7K to 219.92K | |
22-Mar-21 5:17 PM View: | Oncocyte Corp (OCX) | 19-Mar-21 | Market Purchase | 11,000 | $4.79 | $52,702.10 | 11% 102.7K to 113.7K | < 1% |
12-Mar-21 4:35 PM View: | Oxford Immunotec Global Plc (OXFD) | 08-Mar-21 | Disposition | 4,081 | $22.00 | $89,782.00 | (100%) 4.08K to 0 | < 1% |
04-Aug-20 6:50 PM View: | Oncocyte Corp (OCX) | 03-Aug-20 | Market Purchase | 40,000 | $1.35 | $53,880.00 | 64% 62.7K to 102.7K | 74% |
26-Jun-20 4:05 PM View: | Oxford Immunotec Global Plc (OXFD) | 24-Jun-20 | Grant | 4,081 | -- | -- | 100% 0 to 4.08K | |
01-Apr-20 4:05 PM View: | Oncocyte Corp (OCX) | 31-Mar-20 | Purchase | 18,000 | $2,372.00 | $42,696,000.00 | 40% 44.7K to 62.7K | |
01-Apr-20 4:05 PM View: | Oncocyte Corp (OCX) | 30-Mar-20 | Market Purchase | 27,216 | $2.26 | $61,453.70 | 156% 17.48K to 44.7K | 4% |
31-Jul-18 9:39 PM View: | Oncocyte Corp (OCX) | 26-Jul-18 | Purchase | 17,482 | -- | -- | 100% 0 to 17.48K | |
04-Feb-14 2:54 PM View: | Invitrogen Corp. (LIFE) | 03-Feb-14 | Disposition | 7,357 | $76.13 | $560,097.00 | (100%) 7.36K to 0 | 99% |
03-Apr-13 9:19 PM View: | Invitrogen Corp. (LIFE) | 02-Apr-13 | Payment of Exercise | 1,213 | $65.75 | $79,754.80 | (14%) 8.57K to 7.36K | 99% |
03-Apr-13 9:19 PM View: | Invitrogen Corp. (LIFE) | 02-Apr-13 | Option Exercise | 3,067 | $65.75 | $201,655.00 | 56% 5.5K to 8.57K | (99%) |
05-Feb-13 5:28 PM View: | Invitrogen Corp. (LIFE) | 01-Feb-13 | Payment of Exercise | 1,399 | $65.24 | $91,270.80 | (20%) 6.9K to 5.5K | 99% |
05-Feb-13 5:28 PM View: | Invitrogen Corp. (LIFE) | 01-Feb-13 | Option Exercise | 3,572 | $65.24 | $233,037.00 | 107% 3.33K to 6.9K | (99%) |
01-May-12 8:22 PM View: | Invitrogen Corp. (LIFE) | 27-Apr-12 | Market Purchase | 3,330 | $46.49 | $154,814.00 | 100% 0 to 3.33K | (99%) |
23-Dec-10 2:08 PM View: | Clarient, Inc. (CLRT) | 22-Dec-10 | Disposition | 500,000 | $5.00 | $2,500,000.00 | (100%) 500.0K to 0 | < 1% |
21-Dec-10 5:19 PM View: | Clarient, Inc. (CLRT) | 17-Dec-10 | Disposition (change in control) | 72,500 | $5.00 | $362,500.00 | (13%) 572.5K to 500.0K | (< 1%) |
03-Dec-10 7:38 PM View: | Cardiac Science Corporation (CSCX) | 01-Dec-10 | Disposition (change in control) | 1,000 | $2.30 | $2,300.00 | (100%) 1.0K to 0 | < 1% |
05-Nov-10 6:07 PM View: | Cardiac Science Corporation (CSCX) | 05-Nov-10 | Option Exercise | 1,000 | -- | -- | 100% 0 to 1.0K | |
09-Jun-10 2:48 PM View: | Clarient, Inc. (CLRT) | 08-Jun-10 | Grant | 500,000 | -- | -- | 690% 72.5K to 572.5K | |
15-Mar-10 3:58 PM View: | Clarient, Inc. (CLRT) | 12-Mar-10 | Market Purchase | 12,000 | $2.41 | $28,920.00 | 20% 60.5K to 72.5K | 1% |
19-Sep-08 8:23 AM View: | Clarient, Inc. (CLRT) | 18-Sep-08 | Market Purchase | 7,500 | $1.93 | $14,510.20 | 14% 53.0K to 60.5K | 30% |
08-May-07 8:16 PM View: | Clarient, Inc. (CLRT) | 07-May-07 | Market Purchase | 5,000 | $1.92 | $9,600.00 | 10% 48.0K to 53.0K | 31% |
16-Nov-05 2:46 PM View: | Clarient, Inc. (CLRT) | 14-Nov-05 | Market Purchase | 10,000 | $1.19 | $11,880.00 | 26% 38.0K to 48.0K | 112% |
16-Jun-05 7:43 PM View: | Clarient, Inc. (CLRT) | 10-Jun-05 | Market Purchase | 18,000 | $1.40 | $25,250.40 | 90% 20.0K to 38.0K | 79% |
10-Aug-04 10:00 PM View: | Clarient, Inc. (CLRT) | 06-Aug-04 | Market Purchase | 20,000 | $1.15 | $23,000.00 | 100% 0 to 20.0K | 119% |